MYDAYIS- “BAD AD”

anonymous

Guest
how is Mydayis not on the FDA BAD AD list??
selling and promoting ADULT doses in the pediatric market in not only BAD AD worthy but UNETHICAL

There are a growing number of adverse events being reported by 13-17 year olds on Mydayis on adult doses.
 












anecdotal statement on increased AEs unless you work for the agency that received reports (which you dont). As a sales rep maybe you should be in there reiterating the start low go slow strategy.
 






start low go slow???

All of our marketing pieces show efficacy at 37.5. Our PK data compares 37.5 Mydayis to 25 of MAS ER + 12 MAS IR. WITH NO MENTION THAT DOSES HIGHER THAN 25 mg FOR PED PATIENTS HAVE NOT EVER BEEN STUDIED IN PATIENTS LESS THAN 18 yrs of age.


SHIRE was forcing PED reps to give out dosing cards with ADULT dosing from the time of the launch in August.

Giving Pediatricians dosing cards and copay cards without the PED dosing is CARELESS and CRIMINAL.

Start low? Go slow?

Mydayis is only indicated at the LOW doses for PED patients to tell doctors to go slow implies thatthe higher doses are approved
 






anecdotal statement on increased AEs unless you work for the agency that received reports (which you dont). As a sales rep maybe you should be in there reiterating the start low go slow strategy.


Maybe you should of thought about the consequences of having PED reps promote a drug at doses for which it is not indicated.

We don’t get IC data on Vyvanse for under 6 because it is not indicated yet WE DO get incentivized for Mydayis PED rx’s written at the OFF LABEL doses of 37.5 and 50.

Whenever you incentivize reps for RX’s that are written OFF LABEL you are encouraging reps to SELL OFF LABEL. And that is not ANECDOTAL.

THAT IS FACT you scumbag!
 






Maybe you should of thought about the consequences of having PED reps promote a drug at doses for which it is not indicated.

We don’t get IC data on Vyvanse for under 6 because it is not indicated yet WE DO get incentivized for Mydayis PED rx’s written at the OFF LABEL doses of 37.5 and 50.

Whenever you incentivize reps for RX’s that are written OFF LABEL you are encouraging reps to SELL OFF LABEL. And that is not ANECDOTAL.

THAT IS FACT you scumbag!
OMG! FAKE NEWS!! Get a life troll!!
 






Maybe you should of thought about the consequences of having PED reps promote a drug at doses for which it is not indicated.

We don’t get IC data on Vyvanse for under 6 because it is not indicated yet WE DO get incentivized for Mydayis PED rx’s written at the OFF LABEL doses of 37.5 and 50.

Whenever you incentivize reps for RX’s that are written OFF LABEL you are encouraging reps to SELL OFF LABEL. And that is not ANECDOTAL.

THAT IS FACT you scumbag!

If you feel the strongly about this, than tell someone.
 






Maybe you should of thought about the consequences of having PED reps promote a drug at doses for which it is not indicated.

We don’t get IC data on Vyvanse for under 6 because it is not indicated yet WE DO get incentivized for Mydayis PED rx’s written at the OFF LABEL doses of 37.5 and 50.

Whenever you incentivize reps for RX’s that are written OFF LABEL you are encouraging reps to SELL OFF LABEL. And that is not ANECDOTAL.

THAT IS FACT you scumbag!
 






Maybe you should of thought about the consequences of having PED reps promote a drug at doses for which it is not indicated.

We don’t get IC data on Vyvanse for under 6 because it is not indicated yet WE DO get incentivized for Mydayis PED rx’s written at the OFF LABEL doses of 37.5 and 50.

Whenever you incentivize reps for RX’s that are written OFF LABEL you are encouraging reps to SELL OFF LABEL. And that is not ANECDOTAL.

THAT IS FACT you scumbag!
 






Maybe you should of thought about the consequences of having PED reps promote a drug at doses for which it is not indicated.

We don’t get IC data on Vyvanse for under 6 because it is not indicated yet WE DO get incentivized for Mydayis PED rx’s written at the OFF LABEL doses of 37.5 and 50.

Whenever you incentivize reps for RX’s that are written OFF LABEL you are encouraging reps to SELL OFF LABEL. And that is not ANECDOTAL.

THAT IS FACT you scumbag!
 






Maybe you should of thought about the consequences of having PED reps promote a drug at doses for which it is not indicated.

We don’t get IC data on Vyvanse for under 6 because it is not indicated yet WE DO get incentivized for Mydayis PED rx’s written at the OFF LABEL doses of 37.5 and 50.

Whenever you incentivize reps for RX’s that are written OFF LABEL you are encouraging reps to SELL OFF LABEL. And that is not ANECDOTAL.

THAT IS FACT you scumbag!
 






Maybe you should of thought about the consequences of having PED reps promote a drug at doses for which it is not indicated.

We don’t get IC data on Vyvanse for under 6 because it is not indicated yet WE DO get incentivized for Mydayis PED rx’s written at the OFF LABEL doses of 37.5 and 50.

Whenever you incentivize reps for RX’s that are written OFF LABEL you are encouraging reps to SELL OFF LABEL. And that is not ANECDOTAL.

THAT IS FACT you scumbag!

This is why Takeda should and will fire all the useless NBU reps - you learn the label, go through training, yet promote off label? Fucking idiot. Have fun working at McDonald's in 3 months.
 






This is why Takeda should and will fire all the useless NBU reps - you learn the label, go through training, yet promote off label? Fucking idiot. Have fun working at McDonald's in 3 months.
Did you not read any of this? The problem is all the material the PED reps have to give offices has all 4 doses listed. It doesn’t say the highest approved dose is 25mg for 13-17 year olds. So we can be selling on label for what we are telling them, but what we show them or leave behind (dosing card) doesn’t reflect that.